Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Psoriatic Arthritis: A Look Back at Moll & Wright’s Landmark 1973 Paper

Ruth Jessen Hickman, MD  |  Issue: May 2019  |  May 17, 2019

nukeaf / shutterstock.com

nukeaf / shutterstock.com

Psoriatic arthritis came to be viewed as a distinct disease entity with specific clinical features, genetics and pathophysiology only gradually. One important historic development in this transition was a 1973 paper written by a pair of researchers out of Leeds, England: John M. Moll, BSc, DM, and Verna Wright, MD, FRCP.1 Here we discuss the contributions of their paper and how it affected clinical judgments about the disease.

Early Studies in Psoriasis

In the 19th century, several French physicians wrote of the association of psoriasis with arthritis.2 This included the first detailed description of psoriatic arthritis written by Charles Bourdillon in 1888.3 But interest in the disease lagged for several decades. Through case studies and small series, the first half of the 20th century saw a building pile of evidence concerning the association between psoriasis and arthritis.2 The two were largely seen as separate diseases occurring coincidentally, although it was sometimes speculated that psoriasis might be one possible trigger of rheumatoid arthritis.1,4

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“There had been recognition that there was this association between psoriasis and arthritis back in the 19th century,” says Christopher Ritchlin, MD, MPH, a professor of medicine and chief of immunology and rheumatology at University of Rochester Medical Center, N.Y., “but this concept didn’t seem to be high in people’s minds after the initial descriptions. Basically, psoriatic arthritis was considered a form of rheumatoid arthritis.”

This view began to slowly change with the work of several titans of rheumatology. Dr. Wright, Harvey Baker, MB, Walter Bauer, MD, and others began writing of the relationship between psoriasis and arthritis in more detail, including its epidemiological, clinical, serological and histological characteristics.1 Partly based on this work, the American Rheumatism Association (which later became the ACR) first included psoriatic arthritis in its classification of rheumatic diseases in 1964.5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Wright was a leader in the area, and he and his colleagues, working out of Leeds, performed much painstaking research on this topic. For several years, he worked closely with an associate, Dr. Moll. Together, the two published what came to be a critically influential paper, synthesizing and adding to our knowledge of the disease. Simply named “Psoriatic Arthritis,” the paper was published in Seminars in Arthritis & Rheumatism in 1973.1 Since then, the 24-page paper has been cited almost 1,700 times.

The Paper

Dr. Ritchlin

Dr. Ritchlin

“It was this manuscript from the Leeds group that really showed that psoriatic arthritis was a distinct form of arthropathy,” says Dr. Ritchlin. He notes that Dr. Wright was an astute clinical observer who kept copious notes on his patients. “He drew conclusions from what he saw in the clinic. He used these observations to test hypotheses and design studies to carry out the kind of work that led to the seminal findings in this manuscript.”

Luis Espinoza, MD, chief of rheumatology and a professor of medicine at the LSU School of Medicine, New Orleans, agrees the 1973 Moll and Wright manuscript marked an important milestone. “It defined the characteristics and distinctiveness of psoriatic arthritis and provided the basis for considering it distinct from rheumatoid arthritis,” he says.

Dr. Ritchlin adds, “This manuscript went into detail as to why that was the case—in really specific detail.”

In their paper, Moll and Wright provided historical background, discussed terminology and definitions, and reviewed in great detail the existing evidence surrounding psoriatic arthritis. They reviewed epidemiologic, clinical, radiological, laboratory and pathological evidence for psoriatic arthritis as a distinct disease entity. The team also discussed diagnostic problems, genetic and other possible etiological factors, as well as treatment and prognosis.1

Notes Dr. Ritchlin, “There were people who were writing about this earlier, but no one had put everything together in the way this paper did.”

Definitions & Disease Subtypes

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPsoriatic Arthritis Tagged with:Classification CriteriaClassification of Psoriatic Arthritis (CASPAR)criteriaLost & FoundMoll and Wright criteriaPsoriatic Arthritis

Related Articles

    Psoriatic Arthritis: From Leeds to the Limelight

    August 1, 2009

    Advances in understanding of the disease begin in the 1960s

    Looking to Psoriatic Arthritis History to Disrupt Current Thinking

    May 4, 2022

    As the cloud moved away from the tent, Miriam’s skin suddenly became diseased, as white as snow. When Aaron turned toward her, he saw that she was diseased. —Numbers 12:10 ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEFor 29 years he [Fray Pedro de Urraca] was afflicted by … pain, suffering it at once in all the joints…

    Cytokine Targets & Treatment Developments for Psoriatic Arthritis & Spondyloarthritis

    March 15, 2021

    ACR CONVERGENCE 2020—In recent years, a pathophysiological role for the interleukin (IL) 17/IL-23 axis in the development of psoriasis, enthesitis and inflammatory arthritis has been investigated in both rodent and human models. Clinical trials have demonstrated differential benefits for skin disease and joint disease in patients with psoriatic arthritis, axial spondyloarthritis (axSpA) and ankylosing spondylitis…

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    September 20, 2018

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences